An increase of the share capital by Bavarian Nordic A/S was effected on 2 February 2010 by subscription of 3,960,307 shares, with a nominal value of DKK 10 each. Pursuant to section 6 of Executive Order no. 1273 of 16 December 2008 on Issuers' Disclosure Obligations, it is hereby announced that the total nominal value of Bavarian Nordic A/S' share capital is DKK 119,120,520 at the end of February 2010, which is made up of 11,912,052 shares of a nominal value of DKK 10 each corresponding to 11,912,052 votes. Contact Anders Hedegaard, President & CEO. Phone +45 23 20 30 64 Forward-looking statements This announcement includes "forward-looking statements" that involve risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to differ materially from the results discussed in the forward-looking statements. Forward-looking statements include statements concerning our plans, objectives, goals, future events, performance and/or other information that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law. About Bavarian Nordic Bavarian Nordic A/S is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's pipeline is focused in the three areas; biodefence, cancer and infectious diseases, and includes seven development programmes. Two programmes are under preparation for Phase III: IMVAMUNE®, a third-generation smallpox vaccine is being developed under a contract with the US government, and PROSTVAC(TM), a therapeutic vaccine for advanced prostate cancer is being developed under a collaboration agreement with the National Cancer Institute. Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA. For more information please visit www.bavarian-nordic.com <http://www.bavarian-nordic.com/> [HUG#1388699]
Total number of voting rights and share capital in Bavarian Nordic A/S
| Source: Bavarian Nordic A/S